You are here: All Products  > Everest Approved for China Phase II trial of Trodelvy® in TROP-2 Cancers

Everest Approved for China Phase II trial of Trodelvy® in TROP-2 Cancers

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products